Balaji Subramanian is an associate in the London office of Latham & Watkins and a member of the firm’s Antitrust & Competition Practice.

Balaji advises companies and private equity funds on all aspects of UK, European, and international antitrust matters, and on obtaining foreign investment approvals. He has also represented clients on complex antitrust litigation proceedings at the Competition Appeal Tribunal. 

His experience covers several industry sectors, with a focus on technology, life sciences, and media.

Prior to joining Latham, Balaji worked as a managing associate in the antitrust and foreign investment practice of a Magic Circle firm.

Balaji’s experience includes representing: 

  • Sony Interactive Entertainment on its defense against a £5 billion standalone class action at the Competition Appeal Tribunal, as well as investigations by multiple EU national competition authorities* 
  • Novozymes on its €12 billion merger with Chr. Hansen to form Novonesis*
  • Novo Holdings on a range of investments, including the £260 million acquisition of the aquaculture business of Benchmark Genetics*
  • GBST Holdings on the Phase II CMA investigation (and subsequent remittal inquiry) into its completed acquisition by FNZ*
  • Glencore on its $588 million acquisition of the Cerrejón coal mine from its JV partners, Anglo American and BHP*
  • RENK on its $200 million acquisition of David Brown Defence*
  • G4S on its recommended £3.8 billion cash offer from Allied Universal and its takeover defense against a hostile bid from GardaWorld* 
  • ADQ and e& (formerly Etisalat) on their acquisition of a majority stake in StarzPlay Arabia* 
  • Lesaffre on its acquisition of dsm-firmenich’s yeast extract business*

*Matter handled prior to joining Latham

Bar Qualification

  • England and Wales (Solicitor)

Education

  • Postgraduate Diploma in EU Competition Law, King's College London, 2022
  • BA, NALSAR University of Law, 2018
  • LLB, NALSAR University of Law, 2018

Languages Spoken

  • English